Anti-Inflammatory effect of sinomenine by inhibition of pro-Inflammatory mediators in PMA plus A23187-Stimulated HMC-1 Cells

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 9, 2012, Pages 1184-1191

  Oh, Y C ^a,c   Kang, O H ^a   Kim, S B ^a   Mun, S H ^a   Park, C B ^b   Kim, Y G ^b   Kim, Y I ^b   Lee, Y S ^b   Han, S H ^b   Keum, J H ^a   Shin, D W ^b   Ma, J Y ^c   Kwon, D Y ^a  

^a Wonkwang University   (South Korea)

^b Rural Development Administration   (South Korea)

^c Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Cyclooxygenase 2; Inflammatory cytokine; Mitogen Activated protein kinases; Nuclear factor KappaB; Sinomenine

Indexed keywords

CALCIMYCIN; CYCLOOXYGENASE 2; CYTOKINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; SINOMENINE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MAST CELL; POLYMERASE CHAIN REACTION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTI-INFLAMMATORY AGENTS; CALCIMYCIN; CELLS, CULTURED; CYCLOOXYGENASE 2; HUMANS; INFLAMMATION MEDIATORS; MORPHINANS; NF-KAPPA B; PHOSPHORYLATION; TETRADECANOYLPHORBOL ACETATE;

EID: 84867932436     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. YAMASAKI H. Pharmacology of sinomenine, an antirheumatic alkaloid from Sinomenium acutum. Acta Med Okayama 1976; 30: 1-20.
2. LI L, GAO XL, DING BX. Inhibitory effect of sinomenine on H2O2-Induced apoptosis in neonatal rat cardiomyocytes. Zhongguo Zhong Yao Za Zhi 2008; 33: 939-941.
3. CHENG Y, ZHANG J, HOU W, WANG D, LI F, ZHANG Y, YUAN F. Immunoregulatory effects of sinomenine on the T-Bet/GATA-3 ratio and Th1/Th2 cytokine balance in the treatment of mesangial proliferative nephritis. Int Immunopharmacol 2009; 9: 894-899.
4. RONIS MJ, BUTURA A, KOROURIAN S, SHANKAR K, SIMPSON P, BADEAUX J, ALBANO E, INGELMAN-SUNDBERG M, BADGER TM. Cytokine and chemokine expression associated with steatohepatitis and hepatocyte proliferation in rats fed ethanol via total enteral nutrition. Exp Biol Med (Maywood) 2008; 233: 344-355.
5. BECKER S, MUNDANDHARA S, DEVLIN RB, MADDEN M. Regulation of cytokine production in human alveolar macrophages and airway epithelial cells in response to ambient air pollution particles: Further mechanistic studies. Toxicol Appl Pharmacol 2005; 207: 269-275.
6. SHIN HJ, KIM HL, KIM SJ, CHUNG WS, KIM SS, UM JY. Inhibitory effects of chelidonic acid on IL-6 production by blocking NF-?B and caspase-1 in HMC-1 cells. Immunopharmacol Immunotoxicol 2011; 33: 614-619.
7. HONG MH, KIM JH, BAE H, LEE NY, SHIN YC, KIM SH, KO SG. Atractylodes japonica Koidzumi inhibits the production of proinflammatory cytokines through inhibition of the NF-KappaB/IkappaB signal pathway in HMC-1 human mast cells. Arch Pharm Res 2010; 33: 843-851.
8. KANG OH, JANG HJ, CHAE HS, OH YC, CHOI JG, LEE YS, KIM JH, KIM YC, SOHN DH, PARK H, KWON DY. Anti-Inflammatory mechanisms of resveratrol in activated HMC-1 cells: Pivotal roles of NF-KappaB and MAPK. Pharmacol Res 2009; 59: 330-337.
9. JEONG HJ, NA HJ, KIM SJ, RIM HK, MYUNG NY, MOON PD, HAN NR, SEO JU, KANG TH, KIM JJ, CHOI Y, KANG IC, HONG SH, KIM YA, SEO YW, KIM HM, UM JY. Antiinflammatory effect of Columbianetin on activated human mast cells. Biol Pharm Bull 2009; 32: 1027-1031.
10. KANG TH, CHOI IY, KIM SJ, MOON PD, SEO JU, KIM JJ, AN NH, KIM SH, KIM MH, UM JY, HONG SH, KIM HM, JEONG HJ. Ailanthus altissima swingle has antianaphylactic effect and inhibits inflammatory cy-Tokine expression via suppression of nuclear factor-KappaB activation. In Vitro Cell Dev Biol Anim 2009; 46: 72-81.
11. ZHU Z, HOMER RJ, WANG Z, CHEN Q, GEBA GP, WANG J, ZHANG Y, ELIAS JA. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999; 103: 779-788.
12. ROYER B, VARADARADJALOU S, SAAS P, GABIOT AC, KANTELIP B, FÉGER F, GUILLOSSON JJ, KANTELIP JP, AROCK M. Autocrine regulation of cord blood-Derived human mast cell activation by IL-10. J Allergy Clin Immunol 2001; 108: 80-86.
13. STASSEN M, MÜLLER C, ARNOLD M, HÜLTNER L, KLEINHESSLING S, NEUDÖRFL C, REINEKE T, SERFLING E, SCHMITT E. IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-Kappa B is decisively involved in the expression of IL-9. J Immunol 2001; 166: 4391-4398.
14. Barnes PJ, Adcock I. Anti-Inflammatory actions of steroids: Molecular mechanisms. Trends Pharmacol Sci 1993; 14: 436-441.
15. HEISS E, HERHAUS C, KLIMO K, BARTSCH H, GERHÄUSER C. Nuclear factor kappa B is a molecular target for sulforaphane-Mediated anti-Inflammatory mechanisms. J Biol Chem 2001; 276: 32008-32015.
16. HÅVERSEN L, OHLSSON BG, HAHN-ZORIC M, HANSON LA, MATTSBY-BALTZER I. Lactoferrin down-Regulates the LPS-Induced cytokine production in monocytic cells via NF-Kappa B. Cell Immunol 2002; 220: 83-95.
17. BUCKLEY MG, WILLIAMS CM, THOMPSON J, PRYOR P, RAY K, BUTTERFIELD JH, COLEMAN JW. IL-4 enhances IL-3 and IL-8 gene expression in a human leukemic mast cell line. Immunology 1995; 84: 410-415.
18. HSIEH CJ, HALL K, HA T, LI C, KRISHNASWAMY G, CHI DS. Baicalein inhibits IL-1beta-And TNF-Alphainduced inflammatory cytokine production from human mast cells via regulation of the NF-KappaB pathway. Clin Mol Allergy 2007; 5: 5.
19. KIM SJ, JEONG HJ, YI BJ, KANG TH, AN NH, LEE EH, YANG DC, KIM HM, HONG SH, UM JY. Transgenic Panax ginseng inhibits the production of TNF-Alpha, IL-6, and IL-8 as well as COX-2 expression in human mast cells. Am J Chin Med 2007; 35: 329-339.
20. NEWTON R, KUITERT LM, BERGMANN M, ADCOCK IM, BARNES PJ. Evidence for involvement of NF-KappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem Biophys Res Commun 1997; 237: 28-32.
21. KIM JA, KIM DK, KANG OH, CHOI YA, PARK HJ, CHOI SC, KIM TH, YUN KJ, NAH YH, LEE YM. Inhibitory effect of luteolin on TNF-Alpha-Induced IL-8 production in human colon epithelial cells. Int Immunopharmacol 2005; 1: 209-217.
22. CHOI HJ, KANG OH, PARK PS, CHAE HS, OH YC, LEE YS, CHOI JG, LEE GH, KWEON OH, KWON DY. Mume Fructus water extract inhibits pro-Inflammatory mediators in lipopolysaccharide-Stimulated macrophages. J Med Food 2007; 3: 460-466.
23. WU SJ, NG LT. Tetrandrine inhibits proinflammatory cytokines, iNOS and COX-2 expression in human monocytic cells. Biol Pharm Bull 2007; 30: 59-62.
24. OH PS, LIM KT. Plant glycoprotein modulates the expression of interleukin-1beta via inhibition of MAP kinase in HMC-1 cells. Biosci Biotechnol Biochem 2008; 72: 2133-2140.
25. KIM JY, PARK SJ, YUN KJ, CHO YW, PARK HJ, LEE KT. Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-Induced iNOS and COX-2 expression via the attenuation of NF-KappaB in RAW 264.7 macrophages. Eur J Pharmacol 2008; 584: 175-184.
26. GILMORE TD. The Rel/NF-KappaB signal transduction pathway: Introduction. Oncogene 1999; 18: 6842-6844.
27. GILMORE TD. Introduction to NF-KappaB: Players, pathways, perspectives. Oncogene 2006; 25: 6680-6684.
28. BRASIER AR. The NF-KappaB regulatory network. Cardiovasc Toxicol 2007; 6: 111-130.
29. PERKINS ND. Integrating cell-Signalling pathways with NF-KappaB and IKK function. Nat Rev Mol Cell Biol 2007; 8: 49-62.
30. TIAN B, BRASIER AR. Identification of a nuclear factor kappa B-Dependent gene network. Recent Prog Horm Res 2003; 58: 95-130.
31. Chen F, Kuhn DC, Sun SC, Gaydos LJ, Demers LM. Dependence and reversal of nitric oxide production on NF-Kappa B in silica and lipopolysaccharide-Induced macrophages. Biochem Biophys Res Commun 1995; 214: 839-846.
32. ROSHAK AK, JACKSON JR, MCGOUGH K, CHABOT-FLETCHER M, MOCHAN E, MARSHALL LA. Manipulation of distinct NFkappaB proteins alters interleukin-1betainduced human rheumatoid synovial fibroblast prostaglandin E2 formation. J Biol Chem 1996; 271: 31496-31051.
33. SCHMEDTJE JF JR, JI YS, LIU WL, DUBOIS RN, RUNGE MS. Hypoxia induces cyclooxygenase-2 via the NF-KappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997; 272: 601-608.
34. XIE W, MERRILL JR, BRADSHAW WS, SIMMONS DL. Structural determination and promoter analysis of the chicken mitogen-Inducible prostaglandin G/H synthase gene and genetic mapping of the murine homolog. Arch Biochem Biophys 1993; 300: 247-252.
35. XIE QW, KASHIWABARA Y, NATHAN C. Role of transcription factor NF-Kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269: 4705-4708.
36. KRACHT M, SAKLATVALA J. Transcriptional and posttranscriptional control of gene expression in inflammation. Cytokine 2002; 20: 91-106.
37. MAGNANI M, CRINELLI R, BIANCHI M, ANTONELLI A. The ubiquitin-Dependent proteolytic system and other potential targets for the modulation of nuclear factor-KB (NF-KB). Curr Drug Targets 2000; 1: 387-399.